Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Jul 10.

Published in final edited form as: Mutat Res. 2013 April-June;752(1):84–98. doi: 10.1016/j.mrrev.2012.12.001

Table 3.

Cataract risk estimates. Excess odds ratio (/Gy) (+95% CI).

Cohort	Ascertainment	Endpoint	Excess odds ratio (EOR) Gy⁻¹ (95% CI)
Swedish skin haemangioma [227]	LOCSI	Cortical	0.50(0.15, 0.95)
Swedish skin haemangioma [227]	LOCSI	Posterior subcapsular	0.49(0.07, 1.08)
A-bomb AHS [210]	LOCS II	Cortical	0.30(0.10, 0.53)^a
		Posterior subcapsular	0.44(0.19, 0.73)^a
		Nuclear opacity	0.07 (−0.11, 0.30)^a
		Nuclear colour	0.01 (−0.17, 0.24)^a
A-bomb AHS cataract surgery [211]	Surgical removal	All cataract removal	0.32 (0.20, 0.47)
Icelandic airline pilots [228]	WHO	Nuclear	20 (0, 30)
		Cortical	<0(<0, >0)
		Posterior subcapsular	<0(<0, >0)
Chernobyl recovery worker [26]	Merriam-Focht	Non-nuclear stage 1–5	0.65 (0.18, 1.30)
		Posterior subcapsular stage 1	0.42 (0.01, 1.00)
		Nuclear	0.07 (−0.44, 1.04)
		All cataract stage 1–5	0.70 (0.22, 1.38)
US Radiologic technologist [229]	Self-reported removal	All cataract removal	2.0 (−0.7, 4.7)
Finnish interventional radiologists [230]	LOCS II	Cortical or posterior excluding nuclear	−2 (−16, 13)
Finnish interventional radiologists [230]	LOCS II	All opacity	13 (−2, 28)

^a

EOR Sv⁻¹.